D-(-)-3-Phosphoglyceric acid disodium
CAS No. 80731-10-8
D-(-)-3-Phosphoglyceric acid disodium( —— )
Catalog No. M34924 CAS No. 80731-10-8
D-(-)-3-Phosphoglyceric acid disodium (3-Phospho-D-glyceric acid disodium) is an intermediate in glycolysis/gluconeogenesis and the biosynthesis of serine, glycine, and threonine, competitively inhibiting yeast enolase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 61 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 202 | In Stock |
|
| 50MG | 314 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | 712 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-(-)-3-Phosphoglyceric acid disodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-(-)-3-Phosphoglyceric acid disodium (3-Phospho-D-glyceric acid disodium) is an intermediate in glycolysis/gluconeogenesis and the biosynthesis of serine, glycine, and threonine, competitively inhibiting yeast enolase.
-
DescriptionD-(-)-3-Phosphoglyceric acid (3-Phospho-D-glyceric acid) disodium is an important intermediate in the enzyme-catalysed process of glycolysis. D-(-)-3-Phosphoglyceric acid disodium competitively inhibits yeast enolase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80731-10-8
-
Formula Weight230.02
-
Molecular FormulaC3H5Na2O7P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (434.74 mM; Ultrasonic)
-
SMILESC([C@H](C(=O)[O-])O)OP(=O)(O)[O-].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ramos ML, Justino LL, Gil VM, Burrows HD. NMR and DFT studies of the complexation of W(VI) and Mo(VI) with 3-phospho-D-glyceric and 2-phospho-D-glyceric acids. Dalton Trans. 2009;(43):9616-9624. ?
molnova catalog
related products
-
Mito-LND
Mito-LND is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation.
-
Thalidomide-O-amido-...
Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
-
Ingenol
Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.
Cart
sales@molnova.com